48 related articles for article (PubMed ID: 2165234)
1. Wild type human p53 is antiproliferative in SV40-transformed hamster cells.
Mercer WE; Amin M; Sauve GJ; Appella E; Ullrich SJ; Romano JW
Oncogene; 1990 Jul; 5(7):973-80. PubMed ID: 2165234
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of p53 protein in human tumors.
Inoue K; Kurabayashi A; Shuin T; Ohtsuki Y; Furihata M
Med Mol Morphol; 2012 Jun; 45(3):115-23. PubMed ID: 23001293
[TBL] [Abstract][Full Text] [Related]
3. Repression of RNA polymerase I transcription by the tumor suppressor p53.
Zhai W; Comai L
Mol Cell Biol; 2000 Aug; 20(16):5930-8. PubMed ID: 10913176
[TBL] [Abstract][Full Text] [Related]
4. p53 is a general repressor of RNA polymerase III transcription.
Cairns CA; White RJ
EMBO J; 1998 Jun; 17(11):3112-23. PubMed ID: 9606193
[TBL] [Abstract][Full Text] [Related]
5. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells.
Eizenberg O; Faber-Elman A; Gottlieb E; Oren M; Rotter V; Schwartz M
Mol Cell Biol; 1996 Sep; 16(9):5178-85. PubMed ID: 8756675
[TBL] [Abstract][Full Text] [Related]
6. Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant.
Rowan S; Ludwig RL; Haupt Y; Bates S; Lu X; Oren M; Vousden KH
EMBO J; 1996 Feb; 15(4):827-38. PubMed ID: 8631304
[TBL] [Abstract][Full Text] [Related]
7. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation.
Slingerland JM; Jenkins JR; Benchimol S
EMBO J; 1993 Mar; 12(3):1029-37. PubMed ID: 8458321
[TBL] [Abstract][Full Text] [Related]
8. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin.
Johnson P; Chung S; Benchimol S
Mol Cell Biol; 1993 Mar; 13(3):1456-63. PubMed ID: 8441390
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma.
Joypaul BV; Hopwood D; Newman EL; Qureshi S; Grant A; Ogston SA; Lane DP; Cuschieri A
Br J Cancer; 1994 May; 69(5):943-6. PubMed ID: 8180028
[TBL] [Abstract][Full Text] [Related]
10. The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells.
Quartin RS; Cole CN; Pipas JM; Levine AJ
J Virol; 1994 Mar; 68(3):1334-41. PubMed ID: 8107198
[TBL] [Abstract][Full Text] [Related]
11. Gain-of-function mutations of the p53 gene induce lymphohematopoietic metastatic potential and tissue invasiveness.
Hsiao M; Low J; Dorn E; Ku D; Pattengale P; Yeargin J; Haas M
Am J Pathol; 1994 Sep; 145(3):702-14. PubMed ID: 8080050
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 alterations in human astrocytomas using frozen tissue sections for the polymerase chain reaction.
Aka K; Bruner JM; Bondy ML; Ligon K; Nishi T; del Giglio A; Moser RP; Levin VA; Saya H
J Neurooncol; 1993 May; 16(2):125-33. PubMed ID: 7904621
[TBL] [Abstract][Full Text] [Related]
13. Nuclear accumulation of p53 in normal human fibroblasts is induced by various cellular stresses which evoke the heat shock response, independently of the cell cycle.
Sugano T; Nitta M; Ohmori H; Yamaizumi M
Jpn J Cancer Res; 1995 May; 86(5):415-8. PubMed ID: 7790313
[TBL] [Abstract][Full Text] [Related]
14. Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer.
Uchida T; Wada C; Shitara T; Egawa S; Koshiba K
Br J Cancer; 1993 Oct; 68(4):751-5. PubMed ID: 7691145
[TBL] [Abstract][Full Text] [Related]
15. Growth suppression by p16ink4 requires functional retinoblastoma protein.
Medema RH; Herrera RE; Lam F; Weinberg RA
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6289-93. PubMed ID: 7603984
[TBL] [Abstract][Full Text] [Related]
16. p53 functions as a cell cycle control protein in osteosarcomas.
Diller L; Kassel J; Nelson CE; Gryka MA; Litwak G; Gebhardt M; Bressac B; Ozturk M; Baker SJ; Vogelstein B
Mol Cell Biol; 1990 Nov; 10(11):5772-81. PubMed ID: 2233717
[TBL] [Abstract][Full Text] [Related]
17. Complex formation between the lymphotropic papovavirus large tumor antigen and the tumor suppressor protein p53.
Symonds H; Chen JD; Van Dyke T
J Virol; 1991 Oct; 65(10):5417-24. PubMed ID: 1895390
[TBL] [Abstract][Full Text] [Related]
18. Expression from the murine p53 promoter is mediated by factor binding to a downstream helix-loop-helix recognition motif.
Ronen D; Rotter V; Reisman D
Proc Natl Acad Sci U S A; 1991 May; 88(10):4128-32. PubMed ID: 1851994
[TBL] [Abstract][Full Text] [Related]
19. Modulation of immortalizing properties of human papillomavirus type 16 E7 by p53 expression.
Crook T; Fisher C; Vousden KH
J Virol; 1991 Jan; 65(1):505-10. PubMed ID: 1845904
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
